GE HEALTHCARE TECH.INC. (L0T) — Cash Flow Reinvestment Rate

Latest as of March 2026: 0.66x

GE HEALTHCARE TECH.INC. (L0T) has a Cash Flow Reinvestment Rate of 0.66x as of March 2026, reinvesting €191.00 Million (capex €178.00 Million plus investments €-13.00 Million) from operating cash flow of €290.00 Million. Check how high is GE HEALTHCARE TECH.INC.'s earnings quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.66x
(Capex + Investments) / Operating CF

Total Reinvested

€191.00 Million
Capex + Investments

Operating Cash Flow

€290.00 Million
EUR

Capital Expenditures

€178.00 Million
EUR

GE HEALTHCARE TECH.INC. Cash Flow Reinvestment Rate (2022–2025)

Historical reinvestment intensity for GE HEALTHCARE TECH.INC. across 4 annual periods. Explore long-term investment intensity of GE HEALTHCARE TECH.INC. to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for GE HEALTHCARE TECH.INC. (2022–2025)

Year-by-year capital reinvestment analysis for GE HEALTHCARE TECH.INC.. For live market cap and broader valuation context, see L0T stock market capitalisation.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 0.30x €600.00 Million €1.99 Billion €482.00 Million ▲ +33.6%
2024 0.23x €441.00 Million €1.95 Billion €401.00 Million ▲ +9.2%
2023 0.21x €435.00 Million €2.10 Billion €387.00 Million ▲ +18.6%
2022 0.17x €369.00 Million €2.11 Billion €310.00 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow